Why VBI Vaccines (NASDAQ: VBIV) Could Be a Contrarian Investor’s Dream
While the list of those garnering the most attention read like the usual suspects, there’s probably one biotech firm you haven’t heard of, VBI Vaccines (NASDAQ:VBIV). While VBIV stock soared to multi-year highs around mid-July, shares have found themselves plummeting back to earth. As several now well-known vaccine companies have entered into late-stage clinical trials for their Covid-19 candidates, the other, smaller names have lost their luster.
Filecoin Could Be the Ultimate Disrupter
QEBR (OTC Pink: QEBR) has 300 machines configured to engage the Filecoin (FIL) network. Based on internal estimates, each machine has the possibility to mine 358 Filecoin reward tokens per month. At an expected price of $22.52 per coin, QEBR, assuming no changes to the hardware count, could generate nearly $2.42 million in revenue per month.
Dell (DELL) and Intel (INTC) Backing iAbra’s Virolens “20 Second” COVID-19 Test
US media hasn’t picked up on the linkage to DELL and INTC. The potential of a 20 second COVID-19 test is “priceless”. The existence of this test allows governments to loosen social distancing restrictions as they get used at schools, universities, airports, hospitals, sporting events...the list is endless!
The One Factor That May Distinguish Can-Fite BioPharma (CANF)
This is a play on the treatment of Covid-19 rather than a preventative vaccine Before the pandemic, one of the flagship drugs under the Can-Fite pipeline was Piclidenoson. An orally administered drug, Piclidenoson is essentially a small-molecule inhibitor that targets enzymes that cause inflammation.
Your Step-by-Step Guide to Investing in Australian Stocks
It’s a big world out there. While investors should maintain their core holdings in strong, U.S.-based companies with reasonable growth and earnings trajectories, the...
Small-Cap Gold and Silver Stocks to Buy to Profit from the Crisis
Due to the unprecedented crisis that is the novel coronavirus pandemic, investors are scrambling for the best sector in which to protect their money....
Could COVID-19 Concerns Be Helping To Drive Sales of Glucose Health’s (OTC Pink: GLUC)...
As more information becomes available pertaining to the Coronavirus pandemic and the association with certain pre-existing medical conditions, health experts are growing concerned about...
5 Pandemic Stocks to Buy That Are Off the Beaten Path
With the dramatic changes inherent in the novel coronavirus pandemic, it was no surprise that virtually all investment sectors tumbled in the immediate aftermath....
CytoDyn’s (CYDY) 100% Above Market Offering Stuns the Street
It is very rare for a stock to command a 100% premium in what amounts to a secondary offering unless there is something very...
Xalles Holdings Inc. (XALL) Growing Through Synergistic Acquisitions
Xalles Holdings (OTC: XALL), a financial technology holdings company, led by CEO Thomas Nash, has been the poster child for future CEO’s to mirror their...
Latest News
Nightfood (OTCQB: NGTF) Receives Purchase Orders for Nationwide Hotel Launch
Nightfood Holdings, Inc. (OTCQB: NGTF), the sleep-friendly snack company addressing the $50 billion Americans spend annually on nighttime snacks, announced it has received its...
